References
- Ferrer Baixaulí F, Vento Torres D, Martínez Lorente A, Llombart Bosch A, Carda Batalla C, Marco Algarra J. Angiosarcoma of the outer ear: A case report. Acta Otorrinolaringol Esp. 1999;50(4):311-4. PubMed | Google Scholar
- Durbeca M, Couloignerb V, Troncheb S, Albertc S,
Kanitakisd J, Ltaief Boudriguae A, Malardf O, Maubecg
E, Mourrain Langloish E, Navaillesi B, Peuvrelj L,
Phulpink B, Thimonniera J-C, Disanta F,
Dolivetl G. Recommandations de la SFORL. Bilan d’extension et principes
d’exérèse des tumeurs de la face et du cou à point de départ cutané.
Annales françaises d’oto-rhino-laryngologie et de pathologie cervico-faciale.2014
; 131: 360-369. Google
Scholar
- Abdulhafez Selim, Amor Khachemoune, Norman Lockshin A. Angiosarcoma: A Case Report and Review of the Literature. continuing medical education. 2005;76(5):313-317. PubMed | Google Scholar
- Leighton SE, Levine TP. Angiosarcoma of the external ear: a case report. Am J Otol. 1991;12(1):54-56. PubMed | Google Scholar
- Claudia Andrä, Josefine Rauch, Minglun Li, Ute Ganswindt, Claus Belka, Ladan Saleh-Ebrahimi, Hendrik Ballhausen, Silke Birgit Nachbichler, and Falk Roeder. Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck. Radiat Oncol. 2015;10:140. PubMed | Google Scholar
- Mark RJ, Tran LM, Sercarz J et al. Angiosarcoma of the head and neck: The UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg. 1993;119(9):973-978. PubMed | Google Scholar
- Budd GT. Management of angiosarcoma. Curr Oncol Rep. 2002;4(6):515-519. PubMed | Google Scholar
- Fujisawa Y, Yoschino K, Kadono T, Miyagawa T, Nakamura Y, Fujimoto M. Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: A multicentre, retrospective study. British Journal of Dermatology. 2014;171(6):1493-1500. PubMed | Google Scholar
- Fury MG, Antonescu CR, Van Zee KJ et al. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with sugery and chemotherapy. Cancer J. 2005;11(3):241-247. PubMed | Google Scholar
- Fayette J, Martin E, Piperno-Neumann S et al. Angiosarcomas, a herogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol. 2007;18(12):2030-2036. PubMed | Google Scholar
- Fata F, O’Reilly E, Ilson D et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999; 86(10):2034-2037. PubMed | Google Scholar
- Penel N, Binh NB, Bay JO et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the AngioTax study. J Clin Oncol. 2008;26(32):5269-5274. PubMed | Google Scholar
<